Search - tctmd.com

Displaying 641 - 660 of 878

Sort: Relevancy | Date

News Conference News TCT 2012

Positive Results Seen with Angioplasty for Critical Hand Ischemia

October 25, 2012

News Conference News TCT 2012

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

October 25, 2012

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

Presentation TCT 2012

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Presenter: Francesco Liistro

October 25, 2012

Presentation TCT 2012

Design and Rationale of ISCHEMIA

Presenter: David Maron

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

Presentation TCT 2012

Evolutionary Revascularization Strategies for Coronary Artery Disease: From Anatomy to Ischemia to Vulnerable Plaque

Presenter: Gregg Stone

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

Presentation TCT 2012

Advanced Directive: Treat Only Ischemia-Producing Lesions! The Mandate for Functional Guidance Before or During PCI

Presenter: Bernard De Bruyne

October 24, 2012

Presentation TCT 2012

TCT-7. Plaque Excision as a Treatment Option for Critical Limb Ischemia: 1-Year Results of the DEFINITIVE LE Study

Presenter: James McKinsey

October 23, 2012

Presentation TCT 2012

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

Presenter: Eugenio Stabile

October 23, 2012

Presentation TCT 2012

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Presenter: Bernard De Bruyne

October 23, 2012

Presentation TCT 2012

Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Con!

Presenter: Alex Powell

October 23, 2012

Presentation TCT 2012

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Pro!

Presenter: Thomas Zeller

October 23, 2012

News Industry News

The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions

October 23, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

News Conference News TCT 2012

Novel Drug Safe, Effective for Prevention of Peri-operative Cardiac Ischemia Reperfusion Injury

October 23, 2012

Advertisement

Positive Results Seen with Angioplasty for Critical Hand Ischemia

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

More Data Needed on Renal Denervation

DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee...

Design and Rationale of ISCHEMIA

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

Evolutionary Revascularization Strategies for Coronary Artery Disease: From Anatomy to Ischemia to Vulnerable Plaque

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

Advanced Directive: Treat Only Ischemia-Producing Lesions! The Mandate for Functional Guidance Before or During PCI

TCT-7. Plaque Excision as a Treatment Option for Critical Limb Ischemia: 1-Year Results of the DEFINITIVE LE Study

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

Is Ischemia a Marker of Plaque Vulnerability and Future Thrombosis?

Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Con!

Debate III. Is Long-term Patency Following Tibial Intervention for Critical Limb Ischemia Necessary? Pro!

The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

Novel Drug Safe, Effective for Prevention of Peri-operative Cardiac Ischemia Reperfusion Injury

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content